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Background. To characterize participant reasons for withdrawing from a diabetes focused longitudinal clinical observational trial
(TEDDY) during the first three study years.Methods. 8677 childrenwere recruited into the TEDDY study. At participant withdrawal
staff recorded any reason parents provided for withdrawal. Reasons were categorized into (1) family characteristics and (2) protocol
reasons. Families who informed staff of their withdrawal were classified as active withdrawals (AW); families without a final contact
were considered passive withdrawals (PW). Results. Withdrawal was highest during the first study year (𝑛 = 1220). Most families
were AW (𝑛 = 1549; 73.4%). PWwas more common in the United States (𝑛 = 1001; 37.8%) and among young mothers (𝑝 = 0.001).
The most frequent protocol characteristic was blood draw (55%) and the most common family reason was not having enough time
(66%). The blood draw was more common among female participants; being too busy was more common among males. Both
reasons were associated with study satisfaction. Conclusions. Results suggest that, for families of children genetically at risk for
diabetes, procedures that can be painful/frightening should be used with caution. Study procedures must also be considered for the
demands placed on participants. Study satisfaction should be regularly assessed as an indicator of risk for withdrawal.
1. Introduction
The Environmental Determinants of Diabetes in the Young
(TEDDY) study is a multicenter longitudinal clinical obser-
vational trial studying the natural history of the development
of type 1 diabetes (T1DM) in children. Soon after birth,
children were tested for HLA conferred genetic risk for
T1DM. Children with the highest genetic risk were invited to
participate in TEDDY. The purpose of the TEDDY study is
to identify environmental factors that trigger autoimmunity
and TIDM [1].
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The success of longitudinal research studies, investigating
important factors that contribute to T1DM, like TEDDY, is
dependent upon study retention. It is important to inves-
tigate what study and psychosocial characteristics prompt
families to leave a study in order to (1) implement possible
preventive actions to increase retention and (2) design future
longitudinal studies for this at-risk T1DM population in ways
that enhance study retention. Although this topic is critical
for the success of longitudinal trials, the extant literature
is somewhat sparse. In fact, only 55% percent of pediatric
trials report refusal or withdrawal reasons based on a recent
literature review [2]. Previous work within more varied
pediatric populations and interventional studies (e.g., T1DM,
asthma, and obesity intervention trials) has suggested that a
number of sociodemographic factors (e.g., older child age,
minority status, and lower income) and psychological factors
(e.g., greater depression and lower quality of life) were related
to study withdrawal [3–6]. However, these findings from
intervention studies in chronic illness populationsmay not be
fully applicable to the TEDDY at-risk for T1DM population.
Further, previous studies have tended to focus on existing
characteristics of participants who do not complete a study
rather than directly ascertaining reasons for withdrawal from
the participants themselves.
A longitudinal study similar to the TEDDY study
reported that logistical matters like blood sampling and
lack of time were the reasons most often mentioned by
families who withdrew [7]. In the TEDDY population, we
have reported that characteristics of the study protocol, like
blood draws, and family factors, like being too busy, were the
primary reasons families did not join the study [8]. Study
enrollment was associated with sociodemographic factors
such as whether the child had a mother, father, and/or
sibling with T1DM (first degree relative (FDR)), had an older
mother, was a singleton, or had a sibling already enrolled
in the study. Enrollment rates differed between the TEDDY
countries, with a larger proportion of parents recruited from
the European countries [8].
In other prior works, we identified predictors of with-
drawal during the first year (up to the 15 months’ visit) of
TEDDY among families from the general population (GP)
who had no immediate familymember with T1DM [9]. Study
withdrawal was more common if the mother was young, the
father did not participate, or the study child was female. Also,
mothers of children who withdrew were more likely to report
smoking during pregnancy, abstaining from alcohol, and
reducing their work hours or not working at all during preg-
nancy. Mothers who withdrew were also more likely to fail to
complete items on study questionnaires and to underestimate
their child’s TIDM risk. Among mothers with accurate per-
ceptions of their child’s T1DM risk, highmaternal anxiety was
associated with study withdrawal [9]. This information was
used to identify families at high risk for leaving the TEDDY
study in the first year; these families were then provided
with an intervention to promote retention [10]. While factors
associated with withdrawal could be used to screen for
families at risk of dropout, the effectiveness of interventions
aimed at improving the retention of participants can also be
influenced by the families’ specific reasons for withdrawing.
Thus, in this studywe examineddata fromall familieswho left
TEDDY (bothGP and FDR) during the first three study years,
including sociodemographic and psychosocial variables, and
their reasons for opting out of the study.
2. Methods
2.1. TEDDY Study and Data. The TEDDY study has centers
in four countries (Finland, Germany, Sweden, and the United
States) and is supported by the National Institutes of Health
(NIH). The study protocol includes study visits every three
months from 3-4 months of age until the child is four years
old and biannually thereafter. The study protocol includes
blood draws, nasal swabs, height and weight measurements,
and parental interviews where aspects of the child’s health
are recorded together with different types of life events.
At regular intervals TEDDY parents fill out questionnaires
with demographic questions, health histories, life events,
and parents’ worries and anxiety concerning the child’s
increased genetic risk for T1DM. Parents are also requested
to complete food diaries and collect stool samples. Altogether,
the TEDDY study protocol is very demanding in length and
in terms of the frequency and nature of its components [1].
The collection of cord blood for screening and possible
TEDDY enrollment started in September 1, 2004, and ended
February 28, 2010. A total of 424,788 children were screened
for increased HLA conferred genetic risk for T1DM and
21,589 were HLA eligible [11]. The enrollment rate of families
with children at increased genetic risk was 38.4% from the
general population (GP) and 64.8% from FDR families. The
number and proportion of eligible children as well as the
number of children enrolled differed both between countries
and between GP and FDR families [8].
The earlier a family withdrew from the study, the fewer
data points were available. For all children, demographic fac-
tors like country, gender, month of birth, FDR/GP status, and
mother’s age were obtained in connection with the collection
of cord blood to determine eligibility for TEDDY. Data for
all children enrolled in TEDDY were also available from
the questionnaires that each parent completed in connection
with the first TEDDY visit. These psychosocial measures
contained questions on parents’ views on the child’s risk for
developing diabetes, their worries about that possibility, and
their thoughts on having the child tested for genetic T1DM
risk. The mother also answered questions on lifestyle factors
during pregnancy (smoking and alcohol consumption). For
families withdrawing after the first study year, there were
additional demographic data collected during the first year of
TEDDY, including parents’ education, child ethnic minority
status, only child status, and household crowding. Psychoso-
cial data were collected repeatedly starting at the 3 and 6
months’ visits, at 15 months, at 27 months, and yearly. In the
current study, the psychosocial data collected immediately
before withdrawal were used. These data are worries (e.g.,
How often do you worry that your child will get diabetes:
never/very often), anxiety (short version of the State-Trait
Anxiety Inventory (SAI)) [12], depression (Bradley’s Wellbe-
ing Scale) [13], study satisfaction (three correlated questions
summed into a satisfaction score: Overall, how do you feel
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Figure 1: Study population.
about having your child participate in the TEDDY study? Do
you think your child’s participation in the TEDDY study was
a good decision? Would you recommend the TEDDY study to
a friend?), and risk perception (Compared to other children
do you think your child’s risk to develop diabetes is much
lower/much higher?).
2.2. Data Collection. When a family withdrew from TEDDY,
a Change in Study Participation Form (CSP Form) was filled
out by TEDDY staff and any reason the parent gave for
leaving the study was recorded. More than one reason could
be recorded. If a family did not give a reason for leaving the
study this was also noted. The last visit when any data were
collected from the family was taken as the time of withdrawal
even though the CSP form could be completed at a much
later date. For some families, the decision to withdraw from
TEDDY was difficult and could span over a long period of
time with several cancelled visits and no collection of data
before a final decision to leave the study. If a family did not
come to the clinic for more than a year despite scheduled
visits and did not contribute any data over the course of one
year, the family was considered to be a Passive Withdrawal
(PW) and a CSP Form was completed. Families that became
unavailable and impossible to reach were also PW and were
considered TEDDY withdrawals.
2.3. Statistical Analysis. Differences in frequencies between
categorical groups were tested by chi-square tests. For contin-
uous variables, differences in means were tested by indepen-
dent two-sample 𝑡-tests. Multiple linear regression was used
to examine the association of demographic and psychosocial
variables with specific common reasons for withdrawing.
Demographic variables available on all subjects were exam-
ined first and later psychosocial factors were added. Data
from the last questionnaire prior to withdrawal were used to
estimate maternal anxiety, risk perception, worry, and study
satisfaction. If for any reason there were missing data, infor-
mation was taken from the last questionnaire available. Uni-
variate and multiple logistic regression models were used to
test for significant factors associated with type of withdrawal
(PW versus AW). Analyses were performed using SAS 9.2. 𝑝
values less than 0.05 were considered statistically significant.
3. Results
A total of 8677 children were recruited into the TEDDY
study. From September 1, 2004, until July 31, 2012, there were
2621 CSP forms filled out. CSP forms from all children who
left the study on or before the 3-year visit were selected for
analysis. Figure 1 gives an overview of how the study cohort
was created. In all, 512 formswere excluded from the study for
reasons outlined in the figure, resulting in 2109 CSP forms
describing the first time withdrawal of the family from the
study. Of these, 1549 forms came from families who told the
staff they wanted to withdraw from TEDDY (AW); 90% gave
at least one reason why they opted out. A total of 560 families
(26.6%) did not respond to repeated scheduling attempts
for more than a year or became impossible to contact and
were withdrawn by the TEDDY staff without any further
contact (PW). In Figure 2, the number of AW and PW
for the different countries is shown by visit. Overall, study
withdrawal was highest during the first year of the study and
decreased thereafter andAWwas farmore common than PW.
The United States had the highest frequency of PW (𝑛 = 378;
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Figure 2: Number of withdrawals by age of last visit and by country divided into passive withdrawals (PW) (checked) and active withdrawals
(AW) (white).
23.9%) and the relative proportion of PW increased over
time. Finland had the lowest PW rate (𝑛 = 34; 8.9%) and it
remained low across all study years. In Germany 39 children
(23.9%) and in Sweden 109 children (19.0%) were classified
as PW. There was a significantly increasing trend of PW
proportion over the study period in Germany (𝑝 = 0.024)
and Sweden during the three years (𝑝 = 0.001) even though
the number of both PW and AW decreased.
Univariate and multiple regressions were used to identify
factors that differentiated between AW and PW. PW were
significantly more common in other countries compared to
Finland, among young moms, and in older children. In the
univariate models, high anxiety, maternal smoking during
pregnancy, and lack of father participation in TEDDY were
associated with PW. However, these factors did not remain
significant in the multivariate model (Table 1).
Table 2 depicts characteristics of the AW by age of the
child at the time of withdrawal. In the first half year after
enrollment, 24.1% of the AWwere youngmothers (<25 years)
which was significantly different compared to year 3 when
14.8%were youngmothers.The earlyAWwere alsomore anx-
ious mothers (<0.001) andmothers more worried about their
child developing diabetes (𝑝 = 0.003) compared to those
remaining in the study.There were no significant associations
between the accuracy of the mother’s T1DM risk perception
or study satisfaction and the child’s age at withdrawal.
The frequencies of different reasons reported by the AW
distributed over visits during the three study years are shown
Journal of Diabetes Research 5
Table 1: Factors associated with passive withdrawal (PW) versus active withdrawal (AW).
Factorsa
Number
mean (SD)
Univariate Multivariate
% of PW OR 95% CI 𝑝 value OR 95% CI 𝑝 value
Country of residence
Finland 383 8.9 1.00 Ref. 1.00 Ref.
Sweden 562 19.4 2.47 1.64–3.72 2.86 1.85–4.44
Germany 163 23.9 3.22 1.95–5.34 3.73 2.16–6.43
US 1001 37.8 4.28 3.26–9.06 <0.001 6.57 4.35–9.93 <0.0011
Maternal age at child’s birth (years)
Years 28.9 (5.7) 0.94 0.93–0.96 <0.001 0.95 0.93–0.97 <0.001
<29 years 1016 32.0
≥29 years 1093 21.5
Child’s age of withdrawal (years)
Years 1.16 (0.80) 1.12 0.99–1.25 0.08 1.33 1.16–1.52 <0.001
<1.16 years 1231 25.8
≥1.16 years 878 27.6
Gender
Female 1094 25.9 1.00 Ref. 1.00 Ref.
Male 1015 27.3 1.08 0.88–1.31 0.46 1.10 0.88–1.36 0.40
FDRa
No 1957 26.8 1.00 Ref. 1.00 Ref.
Yes 152 23.7 0.85 0.57–1.25 0.41 0.95 0.62–1.47 0.81
Smoking during pregnancy
No 1556 25.2 1.00 Ref. 1.00 Ref.
Yes 415 30.4 1.30 1.02–1.64 0.03 1.31 1.00–1.72 0.05
Alcohol 3rd trimester
No 1713 26.1 1.00 Ref. 1.00 Ref.
Yes 289 27.3 1.07 0.81–1.41 0.66 1.16 0.85–1.60 0.35
Worked during pregnancy
No or reduced hours 1184 26.6 1.00 Ref. 1.00 Ref.
Yes or increased hours 819 25.8 0.96 0.78–1.17 0.67 0.92 0.74–1.15 0.45
High anxiety (SAI > 48)
Score 40.9 (10.7) 1.02 1.01–1.03 <0.001 1.00 0.99–1.01 0.80
<40.9 score 1059 22.6
≥40.9 score 921 29.4
Risk perception
Underestimate 901 27.3 1.00 Ref. 1.00 Ref.
Accurate 1097 25.2 0.90 0.73–1.09 0.28 0.99 0.80–1.23 0.93
Father not active (3mo)b
No 1807 25.0 1.00 Ref. 1.00 Ref.
Yes 302 36.1 1.70 1.31–2.20 <0.001 1.27 0.90–1.78 0.17
aFDR = first degree relative has type 1 diabetes. bFather did not answer 3-month questionnaires.
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Table 2: Active withdrawals by child’s age of withdrawal and demographic factors, maternal psychosocial factors, and maternal study
satisfaction.
Factors
All
3–36m
(𝑁)
Year 1
3–6m
𝑁 (row %) or
mean (SD)
Year 1
9–12m
𝑁 (row %) or
mean (SD)
Year 2
15–24m
𝑁 (row %) or
mean (SD)
Year 3
27–36m
𝑁 (row %) or
mean (SD)
𝑝 value
Number of active withdrawals 1549 584 (37.7) 324 (20.9) 431 (27.8) 210 (13.6)
Country of residence
Finland 349 106 (30.4) 69 (19.8) 122 (35.0) 52 (14.9)
Sweden 453 167 (36.9) 92 (20.3) 130 (28.7) 64 (14.1)
Germany 124 37 (29.8) 36 (29.0) 38 (30.6) 13 (10.5)
US 623 274 (44.0) 127 (20.4) 141 (22.6) 81 (13.0) <0.001
Gender
Female 811 323 (39.8) 159 (19.6) 232 (28.6) 97 (12.0)
Male 738 261 (35.4) 165 (22.4) 199 (27.0) 113 (15.3) 0.07
First degree relative with T1D
No 1433 534 (37.3) 302 (21.1) 406 (28.3) 91 (13.3)
Yes 116 50 (43.1) 22 (19.0) 25 (21.6) 19 (16.4) 0.30
Maternal age at child’s birth
years 29.4 (5.6) 28.9 (5.8) 29.0 (5.2) 29.6 (5.5) 30.9 (5.5) <0.001
Highly anxious at last visit (SAI > 48)a
No 1241 413 (33.3) 259 (20.9) 375 (30.5) 191 (15.4)
Yes 229 116 (50.7) 55 (24.0) 45 (19.7) 13 (5.7) <0.001
Worry about diabetes at last visita,b
Never or rarely 706 104 (14.7) 166 (23.5) 290 (41.4) 144 (20.4)
Sometimes or very often 344 56 (16.3) 114 (33.1) 113 (33.4) 59 (17.2) 0.004
Risk perception at last visita
Underestimate 692 247 (35.7) 147 (21.2) 207 (30.1) 90 (13.0)
Accurate 783 283 (36.1) 170 (21.7) 213 (27.5) 115 (14.7) 0.63
Study satisfaction at last visita,b
Very satisfied 276 38 (13.8) 77 (27.9) 108 (39.1) 53 (19.2)
Satisfied 289 44 (15.2) 87 (30.1) 99 (34.3) 59 (20.4)
Somewhat satisfied 274 39 (14.2) 71 (25.9) 115 (42.0) 49 (17.9)
Neutral or dissatisfied 208 38 (18.3) 44 (21.2) 84 (40.4) 42 (20.2) 0.47
aIf no measure last visit, the second to last visit is taken if available.
bStudy satisfaction and worry about diabetes are not asked in the first questionnaires so there are fewer available answers at 3 and 6 months.
in Table 3. The different reasons are grouped into “protocol
characteristics” or “family factors.” The two reasons most
frequently given for leaving TEDDYwere concerns about the
blood draw (𝑛 = 359; 55% of all protocol characteristics)
and being too busy/not having enough time (𝑛 = 587; 66.6%
of all family factors). Other frequently mentioned protocol
characteristics included the following: the protocol is too
demanding, transportation difficulties, and the frequency of
visits. Among the family factors, feeling overwhelmed/being
too stressed is the second most common reason given (𝑛 =
206, 23.4%). Having concerns about the blood drawwasmore
often mentioned for older children (𝑝 = 0.039), not wanting
to be reminded of the child’s risk was significantly more often
reported as a reason for withdrawal during the first visits (𝑝 =
0.003), and being too busy/not having enough time was more
often reported in the later visits (𝑝 = 0.037). During the study
period, 11% (𝑛 = 97) of the families cited moving out of the
area as a reason for opting out. A total of 165 families (10.7%)
did not want to give a reason for leaving or only wanted to
wait and see what might happen.
The result of multiple regressions examining demo-
graphic factors in all AW subjects for the two most often
mentioned reasons for withdrawal (concerns about blood
draw and being too busy) is presented in Table 4. German
and US mothers were more likely to report the blood draw
as the reason for leaving TEDDY compared to Finland
and Sweden. Also, the blood draw was mentioned more
often as the child got older and if the child was a girl.
Being too busy was given as the reason for leaving TEDDY
most often among Swedish mothers and least often among
German mothers. This reason was more common in families
with an older TEDDY child and if the child was a boy.
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Table 3: Frequency of common reasons for withdrawing from the TEDDY study during the first three study years. Percentages for reasons
mentioned more frequently are shown.
Withdrawals
Last visit before withdrawal (month)
Year 1 Year 1 Year 2 Year 3 All
3–6m 9–12m 15–24m 27–36m 3–36m
𝑁 (row %) 𝑁 (row %) 𝑁 (row %) 𝑁 (row %) 𝑁 %
Active withdrawals (AW) 584 (37.7) 324 (20.9) 431 (27.8) 210 (13.6) 1549 73.4
Reasons for withdrawal
Protocol characteristics 244 (37.4) 128 (19.6) 195 (29.9) 86 (13.2) 653 100
Concerns about blood draw 124 (34.5) 63 (17.5) 112 (31.2) 60 (16.7) 359 55.0a
Protocol too demanding 68 (40.0) 41 (24.1) 43 (25.3) 18 (10.6) 170 26.0a
Transportation difficulties 44 (41.1) 21 (19.6) 35 (32.7) 7 (6.5) 107 16.4
Concerns about frequency of visits 40 (39.2) 20 (19.6) 33 (32.4) 9 (8.8) 102 15.6
Concerns about stool samples 14 9 13 7 43 6.6
Concerns about questionnaires 15 8 10 4 37 5.7
Food diaries too troublesome 12 1 2 1 34 5.2
Do not want to be reminded of risk 19 6 5 1 31 4.7
Duration of study is too long 1 3 5 1 10 1.5
No treatment to prevent offered 3 1 2 1 7 1.1
Worried about privacy 1 1 0 0 2 —
Worried about loss of insurance 3 0 0 0 3 —
Other protocol characteristics 2 3 5 2 12 1.8
Family factors 279 (35.6) 162 (20.7) 231 (29.5) 112 (14.3) 784 100
Too busy/not enough time 187 (31.9) 134 (22.8) 185 (31.5) 81 (13.8) 587 66.6a
Feeling overwhelmed/stressed 82 (39.8) 40 (19.4) 58 (28.2) 26 (12.6) 206 23.4
Moving out of the study area 33 (30.4) 23 (23.7) 22 (22.7) 19 (19.6) 97 11.0
Child medical/behavioral problems 29 (40.3) 16 (22.2) 16 (22.7) 11 (19.6) 72 8.2
Family member emotional problems 15 9 18 10 52 5.9
Does not want to be in research 9 3 8 5 25 2.8
Family member does not agree to participate 8 0 5 4 17 1.9
Family member in another study 1 0 2 0 3 —
Subject already in another study 0 1 0 0 1 —
Fam. health care provider not recommended 1 0 0 0 1 —
Language barrier 1 0 0 0 1 —
Other family factors 4 2 4 3 13 1.5
Active contact made but no reason given or
wants to wait and see
70 (42.4) 28 (17.0) 42 (25.4) 25 (15.2) 165 10.7
aSignificant difference between age groups: concerns about blood draw (𝑝 = 0.039), do not want to be reminded of risk (𝑝 = 0.003), and too busy/not enough
time (𝑝 = 0.037).
Maternal smoking during pregnancy,mother working during
pregnancy, maternal alcohol consumption during pregnancy,
father participation in TEDDY, and whether the TEDDY
child was a FDR or from the GP were not associated with
either reason for leaving TEDDY.
In Table 5, two logistic regressions explore maternal psy-
chosocial factors in relation to the two most frequently
mentioned factors for withdrawing, concerns about blood
draw and being too busy. The regressions are adjusted for
country of residence, maternal age, age of child at study
withdrawal, and gender. The results show that concerns
about blood draw were associated with the mother’s study
satisfaction both at 6 months and at the last visit before
withdrawal. At both 6 months and the last visit, mothers
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Table 4: Multiple logistic regression examining demographic factors in relation to (a) concerns about blood or (b) being too busy as a reason
for withdrawing among those who actively withdrew.
Factors at enrollment
Demographic measures in relation to concerns about blood draw and being too busy (𝑛 = 1549)
(a) Concerns about blood draw (b) Being too busy
OR 95% CI 𝑝 value OR 95% CI 𝑝 value
Country of residence
Finland 1.00 Ref. 1.00 Ref.
Sweden 1.33 0.91–1.93 1.47 1.10–1.96
US 1.72 1.21–2.43 0.83 0.63–1.09
Germany 7.80 4.89–12.4 <0.001 0.48 0.30–0.77 <0.001
Maternal age at child’s birth (yrs)
Years 1.05 1.02–1.07 <0.001 1.00 0.98–1.01 0.62
Child’s age of withdrawal (months)
Months 1.20 1.03–1.40 0.02 1.15 1.01–1.31 0.04
Gender
Male 1.00 Ref. 1.00 Ref.
Female 1.44 1.12–1.85 0.004 0.78 0.63–0.96 0.02
Note: FDR/GP status, smoking during pregnancy, working during pregnancy, alcohol consumption during pregnancy, and dad’s participation in TEDDY were
not associated with either concerns about blood draw or being too busy.
who reported less satisfaction with TEDDY were more likely
to report concerns about the blood draw as the reason for
leaving TEDDY. The relationship between study satisfaction
and mothers’ report of being too busy as the reason to
leave TEDDY was less clear. No other psychosocial factors
(maternal anxiety or mother’s risk perception) showed an
association with the two most common reasons for leaving
the TEDDY study.
4. Discussion
The TEDDY study, which seeks to identify factors associated
with the development of T1DM, has a demanding protocol
for both the children and their parents. The study is also
longitudinal with four visits to a TEDDY clinic each year
until the child is four years of age and biannually thereafter
until the child is fifteen years of age. After 8 years, 72.2%
of the recruited children are still participating in the study.
The majority of families who left gave a reason for leaving.
PW was more common among the US participants. Being a
large country with a diverse population, it is more difficult
to track people compared to the European countries. We
previously reported that U.S. families often failed to respond
to phonemessages or letters inviting them to join TEDDY [8],
constituting passive refusal, which is similar to PW.
Finland had the lowest number of PW and similar num-
bers over the years, while the proportion of PW in Germany
and Sweden tended to increase during the three study years
even though the total number of withdrawals decreased
significantly. Some study sitesmay keep a TEDDYparticipant
as “active” in TEDDY despite multiple missed visits. After
getting to know TEDDY staff over many months some
families may have difficulty directly telling staff that they are
leaving the study andmay instead just “no-show.”Differences
between study centers in how families are managed might
develop over time and this is a weakness of the current results
reported. However, it is difficult for a large study like TEDDY
to systematically define how staff uniformly manage study
families over many years.
Sociodemographic factors also related to study with-
drawal. PWmothers were younger and more likely to smoke
during pregnancy than those retained in the study. In the
univariate analysis, lack of father participation in TEDDY
was associated with PW but this effect was not statistically
significant in the multivariate model. In previous work, we
found that lack of father participation was an important
predictor of study withdrawal in the first year of TEDDY
[9]. Father involvement in a study may be a more important
determinant ofwhether a family stays in a study orwithdraws;
it may not predict whether the withdrawal is active or passive.
Logistical aspects of the study were found to be common
reasons for withdrawal. Even though TEDDY staff is very
skilled, drawing blood from a small child can be very
challenging and cause unpleasant experiences both for the
child and the parent. Other studies have reported that blood
draws can be an obstacle for study participation and a reason
for opting out [7]. Reporting the blood draw as a reason for
leaving TEDDY was more common later in the study than in
the early phase. All blood draws are done after application of
dermal anesthetics so a baby might react less than a slightly
older child who might have learned to fear the blood draw.
This observation has been verified by Swedish TEDDYnurses
who conducted a parent survey of the child’s reaction to the
blood draw. In fact, parents tended to rate stronger reactions
in older children (personal communication).
Being too busy and not having time to do the TEDDY
tasks was the most frequently mentioned reason for leaving
the study. Being stressed and feeling overwhelmed was
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Table 5: Logistic regression examining maternal psychosocial factors in relation to (a) concerns about blood draw or (b) being too busy as a
reason for withdrawing after adjusting for country of residence, maternal age, child’s age at withdrawal, and gender (see Table 4).
Psychosocial factors
Psychosocial measures in relation to concerns about blood and being too busy after adjusting for
demographic factors (𝑛 ∼ 1031)
(a) Concerns about blood draw (b) Being too busy
OR 95% CI 𝑝 value OR 95% CI 𝑝 value
Maternal high anxiety (SAI > 48)
Score 1.00 0.98–1.01 0.42 0.99 0.98–1.00 0.09
Mother’s risk perception
Underestimate 1.00 Ref. 1.00 Ref.
Accurate 1.01 0.74–1.38 0.95 0.91 0.70–1.18 0.49
Study satisfaction (6mo)
Very satisfied 1.00 Ref. 1.00 Ref.
Satisfied 1.38 0.89–2.15 1.24 0.88–1.74
Somewhat satisfied 1.80 1.16–2.78 1.80 1.27–2.59
Neutral or dissatisfied 2.73 1.68–4.42 <0.001 1.11 0.73–1.69 0.007
Study satisfaction (last visit)
Very satisfied 1.00 Ref. 1.00 Ref.
Satisfied 1.57 0.99–2.49 1.19 0.84–1.69
Somewhat satisfied 2.54 1.61–4.03 1.43 1.00–2.05
Neutral or dissatisfied 2.64 1.62–4.31 <0.001 1.33 0.89–1.97 0.252
another important reason for not participating anymore.
Being busy was significantly more often mentioned as a
reason for withdrawal at the later study visits. It may be
that when a baby is born, the mother is often home caring
for the baby and may not experience the TEDDY tasks as
burdensome, compared to later when shemay return towork.
Also, some TEDDY tasks are easier to complete when the
child is a baby like collecting stool samples or doing a 3-day
food diary. Also, being in the beginning of a study may give
participants a feeling of curiosity and enthusiasm, something
that may disappear as the study seems less novel to families.
Psychological reasons also played a role in withdrawal
for some families, particularly early in the study. Mothers
in families who withdrew early, after the first or second
TEDDYvisit, appeared to bemore anxious andworried about
their child getting diabetes compared to mothers in families
leaving the study at 9 months or later. This is underscored by
the observation that mothers who reported that they did not
want to be reminded of the child’s risk of T1DM as a reason
for withdrawal often left TEDDY after the first two visits.
The two most important factors mentioned as reasons
for withdrawal (blood draw and being too busy) were each
analyzed in separate regression models, first in relation to
demographic factors and in a second model in relation
to maternal psychological factors and study satisfaction.
Reporting the blood draw as a reason for withdrawal was
more common if the child was a girl while stating that the
family was too busy to participate was more common if the
child was a boy. A study on infant pain response following
immunization injection demonstrated that parental behavior
has a key role in influencing how infants respond to painful
procedures with differences between female and male infants
[14].We can only speculate that parentsmay bemore sensitive
to the possible discomfort of the blood draw in girls than in
boys; boys are often expected to be braver than girls. Another
study found that girls’ pain threshold is lower than that of
boys, at least for slightly older children compared to the
TEDDY children in our study [15]. This could indicate that
the reaction of girls to the blood drawmight be stronger than
that of the boys and therefore the parents might be more
prone to opt out when the child is a girl even when the child
is younger.
Why being too busy was more often mentioned when
the child was a boy is harder to explain. Sometimes boys are
more physically active and this may create more problems for
parents in collecting TEDDY samples and data in preparation
for the visit. It may also mean that boys are more likely to
openly protest going to the TEDDY clinic. All this taken
together might give parents a feeling of not having time and
being too busy. In the current study, parents who gave the
blood draw as a reason for leaving often expressed lower
satisfaction with the study both at 6 months, when this
was first assessed in TEDDY, and in the survey completed
before opting out. It is likely that difficulties with the blood
draw were seen early in the study, sometimes continued, and
resulted in lower satisfactionwith theTEDDYexperience and
ultimately withdrawal from the study.
In a prior study exploring reasons of why parents stay in
TEDDY, having someonewatching the child for development
of T1DM was the most often mentioned reason. Among
the minority of parents who had considered leaving the
study, the blood draw, being too busy/not having enough
time, a demanding protocol, and food diaries were the most
frequently reported reasons for considering leaving [16].
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These results are in line with what was found in the present
study.
In this study, reasons for withdrawal were obtained by
the TEDDY staff via interview when the parents decided
to leave TEDDY, while our prior published work collected
this information by questionnaire [16].Therefore, themethod
of obtaining this data does not seem to be important as
the results were similar. What is lacking is a more in-depth
explanation of why parents are too busy and do not have time
to remain in TEDDY. Retention and compliance in a longitu-
dinal study likeTEDDYare critical for the success of the study
so detailed information about why families leave is important
for developing strategies for improving study retention.
5. Conclusion
Results from this study suggest some significant factors that
should be taken into account to counteract opting out in
longitudinal studies focusing on a population at genetic risk
for T1DM like TEDDY. Psychological factors clearly play a
role in early withdrawal and thus early in the study it is
important to record and pay attention to parents’ anxieties
and worries and to implement procedures that may reduce or
address these challenges. Also, young mothers, particularly if
the father is not fully present, are at early risk for leaving the
study and may need extra attention. Procedures that can be
experienced as painful and frightening, like a venous blood
draw, need to be used with great caution and all ways to
facilitate obtaining the specimen need to be considered. It
is important for researchers to carefully think through all
components in the study that might increase the demands on
the participants and it is important to avoid overburdening
families, which may increase the risk of withdrawal. Regular
investigations of the subjects’ satisfaction with the study can
give important information on how the study subjects are
experiencing their participation and can predict withdrawal.
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